Pathways to maintaining HIV latency and suppression
03 February 2021
•
OA14
•
15:00
>
16:00
•
Pathways to maintaining HIV latency and suppression
•
Live channel 3
This session explores mechanisms of immune system control to maintain low viral load and viral latency. New approaches with therapeutic implication are also explored.
15:00
•
OA14.01
•
Improved killing of HIV-infected cells by a combination of three neutralizing and non-neutralizing antibodies
See abstract
15:08
•
OA14.02
•
Unprimed CD8+ lymphocytes promote the maintenance of HIV latency in CD4+ T cells
See abstract
15:16
•
OA14.03
•
Analysis of the early responses to HIV-1 in matched treatment naïve individuals reveals early soluble proteins that are associated with in vivo virus control
See abstract
15:24
•
OA14.04
•
Targeting sphingosine-1-phosphate signaling prevents cell-to-cell transmission of HIV-1
See abstract
15:32
•
OA14.05LB
•
Impact of HIV kick-and-kill therapy on host epigenetic and transcriptional programs in PBMC, and viral rebound after cART interruption
See abstract
15:40
•
OA14.06
•
Live Q&A
See abstract
|